BIO FOR HOPE ACCESS TO LIFE

OVERVIEW

BECAUSE

ACCESS

IS EVERYTHING

Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy life, free from the threat of infectious diseases.

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, UNICEF, and many others.

VISION

OUR VISION

AND

STRATEGY

A Sustainable Business Based on Innovation, Value, and Global Good

Heading Global pioneer in invitro diagnostic technologies

Promote health and well-being of mankind via accurate diagnosis of diseases

REINFORCE MARKET PRESENCE AND DIVERSIFY MARKETS

Reinforce market footing in malaria diagnosis; launch new diagnostic products including tests for COVID-19, G6PD deficiency, dengue fever, influenza, and strep

STRENGTHEN QUALITY CONTROL AND CUSTOMER RELATIONSHIPS

Maintain stringent quality control; strengthen relationships with customers including international agencies, non-profit organizations, and retailers.

DEVELOP VALUE-ADDED PRODUCTS

Build a portfolio of value-added products based on cutting-edge technologies in in vitro diagnostics.

ENHANCE SUSTAINABILITY OF PROFITS

Reduce costs via product diversification, economies of scale, and production automation.

CEO MESSAGE

EACH AND EVERY

LIFE IS PRECIOUS

A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.

Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease.

Our Work Has Just Begun

As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.

Thank you.

CEO MESSAGE

EACH AND EVERY

LIFE IS PRECIOUS

A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.

Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease.

Our Work Has Just Begun

As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance.
With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders.

Thank you.